Evidence map›Paper›PMID 29326804›Full record

ArticleMediterranean journal of hematology and infectious diseases2018

Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso.

Birama Diarra, Albert Théophane Yonli, Pegdwendé Abel Sorgho, Tegwindé Rebeca Compaore, Abdoul Karim Ouattara, Wendpagnangdé Arsène Zongo, Issoufou Tao, Lassina Traore, Serge Théophile Soubeiga, Florencia Wendkuuni Djigma and 5 more

Abstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.Blood transfusion = Trasfusione del sangue · 2019
    Trial
  4. Article
  5. Unrecognized Transmission Risks of Occult Hepatitis B Virus Infection Among Blood Donors in Central Ethiopia.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients.Mediterranean journal of hematology and infectious diseases · 2019
    Article
  18. Review
  19. Article
  20. Insights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina Faso.Mediterranean journal of hematology and infectious diseases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Birama DiarraBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Albert Théophane YonliBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Pegdwendé Abel SorghoBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Tegwindé Rebeca CompaoreBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Abdoul Karim OuattaraBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Wendpagnangdé Arsène ZongoBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Issoufou TaoBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Lassina TraoreBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Serge Théophile SoubeigaBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Florencia Wendkuuni DjigmaBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Dorcas Obiri-YeboahDepartment of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Ghana.
Bolni-Marius NagaloBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Virginio PietraBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.
Rokia SanogoFaculty of Pharmacy, University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Jacques SimporeBiomolecular Research Center Pietro Annigoni (CERBA), BP 364 Ouagadougou 01, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe presence of HBV DNA in the liver (with detectable or undetectable HBV DNA in the serum) of individuals tested HBsAg negative by currently available assays is defined occult B Infection (OBI). It remains a potential transmission threat and risk to HBV chronic infection. The purpose of this study was to determine the OBI prevalence among HBsAg negative subjects and to characterize associated genotypes.

methodsBlood samples of 219 HBsAg-negative subjects tested by ELISA were collected. HBV DNA was investigated in all samples. Viral loads were determined using quantitative real-time PCR. All samples were screened for HBV markers (anti-HBc, anti-HBe, HBsAg). The Pre-S/S region of the HBV genome was sequenced. The database was analyzed using the SPSS and Epi info software. Phylogenetic analysis was performed using the BioEdit and MEGA software.

resultsOf the 219 samples, 20.1% were anti-HBc positive, 1.8% HBeAg and 22.8% were anti-HBe positive. Fifty-six (56) (25.6%) of the samples had a detectable HBV DNA and viral loads ranging from 4 IU/mL to 13.6 10

conclusionThe study reported a prevalence of 7.3% of occult hepatitis B infection. It confirms the predominance of genotype E and the existence of a subgroup of quasi-sub-genotype A3 of HBV in Burkina Faso. It further provides information on the presence of "false OBI." This study has found mutations in the major hydrophilic region (MHR) of the pre-S/S gene of HBV.

Indexed as

GenotypesHBVOBIReal-time PCRSequencing

Identifiers

PMID29326804
PMCPMC5760064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.